Ublituximab Efficacy Outcomes in Relapsing Multiple Sclerosis Patient Subgroups in the ULTIMATE I and II Studies

Drug Category : Array
Conference Category : Array
Lead Author : Hartung P, et al.
Published Date : 26/06/2022
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2022/06/Hartung-1054-TG-EAN-2022-Subpopulations-poster-15Jun22b.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top